Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Effect of the ETA Selective Endothelin Receptor Antagonist Ambrisentan on Digital Ulcers in Patients with Systemic Sclerosis: Results of a Prospective Pilot Study. Chung, L., Arefiev, K., Yaqub, A., Strahs, D., Lingala, B., Fiorentino, D. WILEY-BLACKWELL. 2011: S259–S260
View details for Web of Science ID 000297621500664